Telehealth companies are making a significant impact on how we understand and treat obesity, especially with the surge of new weight loss drugs. One notable company, Ro, recently introduced a unique tool to assess “food noise.” This term describes the constant, often overwhelming thoughts about food that many struggling with obesity experience.
Ro’s new questionnaire was developed alongside academic researchers and aims to see if treatments can help reduce these troubling thoughts. This concept has gained traction recently, particularly with the popularity of GLP-1 drugs like Wegovy and Zepbound, which have been shown to aid weight loss.
Not only is Ro using this scale to monitor patient progress during treatment, but they’re also licensing it to pharmaceutical companies for use in clinical trials. This innovative approach could change how obesity is perceived and treated in medical settings.
Recent studies show that nearly 42% of adults in the U.S. are classified as obese. This number has been rising steadily, making effective treatment options even more crucial. Experts suggest that understanding the psychological aspects of eating, like food noise, can lead to better outcomes for patients.
On social media, users are sharing their experiences with these new medications, often highlighting both their struggles and successes. This has sparked discussions about mental health, body image, and the importance of holistic approaches in weight management.
As obesity remains a growing concern, advancements in telehealth and a deeper understanding of psychological factors may lead to more effective treatments and a shift in how we approach this complex issue. For further reading on the effects of telehealth in obesity treatments, you can check out The Journal of Telemedicine and Telecare.
Source link
biotechnology,Obesity,Pharmaceuticals,STAT+,Telehealth,weight loss
